102 related articles for article (PubMed ID: 2077475)
21. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
[TBL] [Abstract][Full Text] [Related]
22. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma.
Zhao Y; Jiang Y; Wang R; Zheng X; Wang X; Jin B; Lu Y; Qiao T; Hong L; Fan D
Ann Surg Oncol; 2007 Sep; 14(9):2621-7. PubMed ID: 17570016
[TBL] [Abstract][Full Text] [Related]
23. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma.
Yamamoto K; Oka M; Hayashi H; Tangoku A; Gondo T; Suzuki T
Cancer; 1997 May; 79(9):1647-55. PubMed ID: 9128978
[TBL] [Abstract][Full Text] [Related]
24. CYFRA 21-1 serum analysis in patients with esophageal cancer.
Brockmann JG; St Nottberg H; Glodny B; Heinecke A; Senninger NJ
Clin Cancer Res; 2000 Nov; 6(11):4249-52. PubMed ID: 11106239
[TBL] [Abstract][Full Text] [Related]
25. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
26. Monitoring endometrial adenocarcinoma with a four tumor marker combination. CA 125, squamous cell carcinoma antigen, CA 19.9 and CA 15.3.
Matorras R; Rodríguez-Escuderoi FJ; Diez J; Genollá J; Cruz Fombellida J; Ruibal A
Acta Obstet Gynecol Scand; 1992 Aug; 71(6):458-64. PubMed ID: 1326844
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer.
Nakashima S; Natsugoe S; Matsumoto M; Miyazono F; Nakajo A; Uchikura K; Tokuda K; Ishigami S; Baba M; Takao S; Aikou T
Surgery; 2003 Feb; 133(2):162-9. PubMed ID: 12605177
[TBL] [Abstract][Full Text] [Related]
28. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
Oncol Rep; 2003; 10(2):411-4. PubMed ID: 12579281
[TBL] [Abstract][Full Text] [Related]
29. Expression of Sialyl-Tn antigens in normal squamous epithelium, dysplasia, and squamous cell carcinoma in the esophagus.
Ikeda Y; Kuwano H; Baba K; Ikebe M; Matushima T; Adachi Y; Mori M; Sugimachi K
Cancer Res; 1993 Apr; 53(7):1706-8. PubMed ID: 8453646
[TBL] [Abstract][Full Text] [Related]
30. CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group.
Kulpa J; Wójcik E; Radkowski A; Kolodziejski L; Stasik Z
Anticancer Res; 2000; 20(6D):5035-40. PubMed ID: 11326663
[TBL] [Abstract][Full Text] [Related]
31. [The measurement of SCC antigen in squamous cell carcinoma of the lung].
Masuoka T; Matueda Y; Ookawa H; Watanabe K; Mimoto S
Gan No Rinsho; 1985 Jul; 31(8):914-8. PubMed ID: 4032769
[TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G
Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665
[TBL] [Abstract][Full Text] [Related]
34. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
[TBL] [Abstract][Full Text] [Related]
35. [The monitoring of gynecological radiotherapy using serial tumor marker determinations].
Wagner RK; Atzinger A; Breit A
Strahlenther Onkol; 1990 Jul; 166(7):446-52. PubMed ID: 2200151
[TBL] [Abstract][Full Text] [Related]
36. [Squamous cell carcinoma antigen for monitoring patients with head neoplasm].
Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M
Pol Merkur Lekarski; 1999 Nov; 7(41):221-3. PubMed ID: 10680455
[TBL] [Abstract][Full Text] [Related]
37. [Ca 19-9 and Ca 50 in the diagnosis of bronchial carcinoma: comparison with CEA].
Pecchio F; Rapellino M; Oliaro A; Moscato D; Adamo R; Albertino B; Lo Faso C; Faga C; Borasio P
Minerva Med; 1988 Mar; 79(3):183-6. PubMed ID: 2834670
[TBL] [Abstract][Full Text] [Related]
38. [A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma].
Ychou M; Khemissa-Akouz F; Kramar A; Senesse P; Grenier J
Bull Cancer; 2001 Oct; 88(10):1023-7. PubMed ID: 11713038
[TBL] [Abstract][Full Text] [Related]
39. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
[TBL] [Abstract][Full Text] [Related]
40. [Tumor markers in the upper intestinal tract--stomach and pancreas].
Pointner R; Conrad F; Schwab G
Wien Klin Wochenschr; 1989 Jul; 101(14):482-4. PubMed ID: 2773485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
